Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tashkent Political Wire.
Press releases published on September 3, 2025
Carter Credit Union Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims
OKLAHOMA CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Murphy Law Firm is investigating claims on behalf of all individuals whose personal and confidential information was compromised in the data breach involving Carter Credit Union. To join the class action …
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tronox Holdings plc Common Stock and Sets a Lead Plaintiff Deadline of November 3, 2025
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi …
Snap Inc. (SNAP) Faces Securities Class Action Amid Impact of Ad Platform Changes -- Hagens Berman
SAN FRANCISCO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Snap and senior executives, alleging the digital communication company misled investors about its digital ad platform and growth prospects. The …
Xatśūll Appeals Dismissal of Judicial Review Petition Relating to Mount Polley Tailings Storage Facility Raise
VANCOUVER, British Columbia, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (TSX:III) (the “Company” or “Imperial”) announces that the Xatśūll First Nation (“Xatśūll”) has filed a notice of appeal (the “Notice”) today seeking an order …
ROSEN, LEADING INVESTOR COUNSEL, Encourages Flywire Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLYW
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flywire Corporation (NASDAQ: FLYW) between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class …
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages CTO Realty Growth, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CTO, CTO-PA
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CTO Realty Growth, Inc. (NYSE: CTO, CTO-PA) between February 18, 2021 and June 24, 2025, both dates inclusive (the “ …
Securities Fraud Investigation Into Marex Group plc (MRX) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX) on behalf of investors concerning the Company’s possible violations of federal …
AVITA Medical, Inc. (RCEL) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) investors concerning the Company’s possible violations of federal …
Alto Neuroscience, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 19, 2025 Deadline to file Lead Plaintiff Motion.
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Alto Neuroscience, Inc. ("Alto Neuroscience" or the "Company") (NYSE: ANRO) investors of …
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
– Expands Avadel’s pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia – – Initial pharmacokinetic (PK) and comparative bioavailability study to initiate in fourth quarter 2025 …
Radiance Biopharma Signs Exclusive License For ‘First In Class’ c-Met/EGFR Targeted Nano Antibody ADC
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or "Company"), a clinical-stage biotechnology company, announced that it has signed an Exclusive License Agreement with Novatim Immune Therapeutics (Zhejiang) CO., LTD. , (“ …